Status:

COMPLETED

The Effect of Supervised Exercise on Physical Fitness and Energy Expenditure in Post Bariatric Surgery Patients

Lead Sponsor:

University of Texas Southwestern Medical Center

Conditions:

Post-bariatric Surgery

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

It is hypothesized that the patients in the EXDA group will be able to complete a structured exercise program at a level sufficient to accumulate at least 2000 kcal per week, and that the structured e...

Eligibility Criteria

Inclusion

  • RYGB or GB surgery patients who are at least 12 weeks post surgery
  • BMI of 40 or more
  • age 18-70years
  • sedentary lifestyle (energy expenditure of \<35 kcal/kg/day measured by 7-day physical activity recall and no regular moderate physical activity exceeding 20 min/day within the previous 3 months)
  • willingness to alter physical activity in accordance with the intervention programs
  • English or Spanish speaking.

Exclusion

  • body weight \> 180 kg
  • cardiovascular disease
  • pulmonary disease
  • uncontrolled hypertension (resting DBP \>100 or SBP \>180 mm of Hg)
  • visual or hearing impairment
  • functional limitations (difficulty walking one-quarter mile or climbing 10 stairs)
  • abnormal ECG on VO2max test ( \>1 mm ST segment depression at \< 5 METS or with symptoms such as atrial fibrillation, complex ventricular arrhythmias and 3rd degree atrioventricular block)
  • known liver disease due to causes other than nonalcoholic steatohepatitis (liver transaminases \> 2.5 times the upper limits of normal \[SGPT\>105 U/L, SGPT\>120 U/L\] or total bilirubin \>1.5 mg/dL)
  • hematocrit of less than 30%
  • current alcohol abuse (\>7 drinks or 210 g/wk for women and \>14 drinks or 420 g/wk for men)
  • recreational drug abuse
  • current use of any drugs capable of inducing weight loss (e.g., orlistat, sibutramine, topiramate, etc.)
  • major neuro-psychiatric illnesses impeding competence or compliance
  • pregnancy and lactation
  • chronic renal insufficiency (serum creatinine \> 2 mg/dL)
  • untreated thyroid disorders such as hypothyroidism and hyperthyroidism; and 17) bariatric surgical complications including anastomotic leak, wound complications, thrombotic disorders, intestinal obstruction, stomal complications, GI bleeding, recurrent severe abdominal pain, bilious vomiting.

Key Trial Info

Start Date :

July 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2009

Estimated Enrollment :

33 Patients enrolled

Trial Details

Trial ID

NCT00793832

Start Date

July 1 2007

End Date

June 1 2009

Last Update

July 1 2013

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.